Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Qingyu formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Yueyang Hospital of Integrated Chinese and Western Medicine and the Shanghai University of Traditional Chinese Medicine. It is specifically designed to treat dysmenorrhea in patients with adenomyosis, particularly those presenting with the TCM syndrome of qi deficiency and blood stasis. The formula's therapeutic strategy is based on the principles of "strengthening body resistance" (Fuzheng) to address qi deficiency and "removing blood stasis" (Qingyu) to alleviate pain and manage uterine lesions. It is typically administered as oral granules and is currently being evaluated in clinical trials to assess its efficacy in reducing pain scores and improving quality of life compared to placebo.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuzheng qingyu formula.